Great Tree Pharmacy Co., Ltd. (TPEX:6469)
67.70
+0.60 (0.89%)
Sep 8, 2026, 12:16 PM CST
Great Tree Pharmacy Revenue
Great Tree Pharmacy had revenue of 4.74B TWD in the quarter ending June 30, 2026, a decrease of -0.97%. This brings the company's revenue in the last twelve months to 19.02B, up 4.00% year-over-year. In the year 2025, Great Tree Pharmacy had annual revenue of 18.90B with 9.39% growth.
Revenue (ttm)
19.02B
Revenue Growth
+4.00%
P/S Ratio
0.53
Revenue / Employee
42.65M
Employees
446
Market Cap
10.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.90B | 1.62B | 9.39% |
| Dec 31, 2024 | 17.27B | 1.13B | 7.00% |
| Dec 31, 2023 | 16.14B | 1.58B | 10.84% |
| Dec 31, 2022 | 14.56B | 3.28B | 29.11% |
| Dec 31, 2021 | 11.28B | 2.64B | 30.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Standard Chemical & Pharmaceutical | 7.08B |
| Universal Vision Biotechnology | 4.27B |
| Vizionfocus | 4.03B |
| TCM Biotech International | 701.63M |
| Tanvex BioPharma | 657.56M |
| Polaris Group | 67.95M |
| AP Biosciences | 32.25M |